Skip to main content

Advertisement

Table 2 Costs

From: Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis

  South Africa Brazil Bangladesh Tanzania Reference
a. Guidelines
Healthcare provider costs
 First-line treatment, IP, 1mo (excl drugs) 200 (152–230) 333 (117–479) 17 (12–21) 65 (24–106) [16, 18, 19]
 First-line treatment, CP, 1mo (excl drugs) 54 (41–62) 333 (117–479) 11 (7–15) 16 (7–24) [16, 18, 19]
 Drugs, first-line, IP, 1mo 16 7 (6–9) 7 (6–8) 6 [16, 1820]
 Drugs, first-line, CP, 1mo 19 4 (3–6) 3 (3–3) 2 [16, 1820]
 Retreatment: all n/a n/a 213 (160–266) 430 (310–549) [16, 18, 19]
 MDR treatment: all 10,215 (8,619–24,580) 5,223 (4,800–5,348) 4,262 (3,836–4,688) 2,507 (2,454–2,561) [16, 18, 19]
 ART cost in year 1 1,128 (1,117–1,139) 5,875 (5,288–6,463)a 800 (720–880) 315 (283–346) [21, 22, 4952]
 ART cost per year (after year 1) 639 (575–703) 600 (540–660) 277 (249–304) [21, 22, 4952]
Patient costs
 First-line treatment, IP, 1mo 149 (87–164) 40 (8–131) 314 (283–346) 186 (167–204) [3, 16, 17]
 First-line treatment, CP, 1mo 117 (34–129) 40 (8–131) 31 (28–34) 44 (40–48) [3, 16, 17]
 Retreatment: all n/a n/a 135 (121–148) 354 (319–390) [3, 16, 17]
 MDR treatment: all 3,319 (2,987–3,650) 280 (102–1142) 213 (192–234) 454 (409–499) [3, 16, 17]
 ART cost in year 1 106 (96–117) 23 (4–43) 8 (7–8) 24 (22–26) [53]
 ART cost per year (after year 1) 85 (77–93) 9 (2–17) 3 (3–3) 10 (9–11) [53]
 Cost per visit to healthcare facility 8 (7–9) 5 (1–9) 2 (1–2) 5 (4–5) [3, 16, 17]
b. Current
Healthcare provider costs
 First-line treatment, IP, 1mo (excl drugs) 61 (40–96) 133 (59–285) 17 (12–21) 35 (24–45) [16, 18, 19]
 First-line treatment, CP, 1mo (excl drugs) 16 (11–26) 133 (59–285) 11 (8–15) 16 (7–24) [16, 18, 19]
 Drugs, first-line, IP, 1mo 16 7 (6–9) 7 (6–8) 6 [16, 1820]
 Drugs, first-line, IP, 1mo 19 4 (3–6) 3 (3–3) 2 [16, 1820]
 Retreatment: all n/a n/a 213 (160–266) 429 (310–549) [16, 18, 19]
 MDR treatment: all 10,215 (8,619–24,580) 5,223 (4,800–5,348) 4,262 (3,836–4,688) 2,507 (2,454–2,561) [16, 18, 19]
 ART cost in year 1 1,128 (1,117–1,139) 5,875 (5,288–6,463)a 800 (720–880) 315 (283–346) [21, 22, 4952]
 ART cost per year (after year 1) 639 (575–703) 600 (540–660) 277 (249–304) [21, 22, 4952]
Patient costs
 First-line treatment, IP, 1mo 60 (35–66) 40 (8–131) 314 (283–346) 144 (139–149) [3, 16, 17]
 First-line treatment, CP, 1mo 27 (8–30) 40 (8–131) 31 (28–34) 41 (37–44) [3, 16, 17]
 Retreatment: all n/a n/a 135 (121–148) 354 (319–390) [3, 16, 17]
 MDR treatment: all 3,319 (2,987–3,650) 280 (102–1,142) 213 (192–234) 454 (409–499) [3, 16, 17]
 ART cost in year 1 106 (96–117) 23 (4–43) 8 (7–8) 24 (22–26) [53]
 ART cost per year (after year 1) 85 (77–94) 9 (2–17) 3 (3–3) 10 (9–11) [53]
 Cost per visit to healthcare facility 8 (7–9) 5 (1–9) 2 (1–2) 5 (4–5) [3, 16, 17]
  1. IP intensive phase, CP continuation phase, mo month, excl excluding, ART antiretroviral treatment, MDR multidrug resistant, DST drug resistance testing
  2. aAverage cost per year